A newborn receives vitamin K (phytonadione) intramuscularly at birth. What is the primary rationale for this administration?
-
A
To prevent neonatal infection
-
B
To stimulate the immune system
-
C
To prevent hemorrhagic disease of the newborn due to low clotting factors
-
D
To promote bilirubin conjugation